Cheema, P. K., Perdrizet, K. A., Sangha, R. S., Breadner, D., Daaboul, N., Farley, S., . . . Kassam, S. (2026). Early Experience with Tarlatamab (T-Cell Engagers) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Canada: Lessons Learned and Implementation Strategies. Current Oncology, 31(2), 84-111.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Cheema, Parneet K., et al. "Early Experience with Tarlatamab (T-Cell Engagers) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Canada: Lessons Learned and Implementation Strategies."
Current Oncology 31, no. 2 (2026): 84-111.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Cheema, Parneet K., et al. "Early Experience with Tarlatamab (T-Cell Engagers) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Canada: Lessons Learned and Implementation Strategies."
Current Oncology, vol. 31, no. 2, 2026, pp. 84-111.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.